Clinical Trials Directory

Trials / Completed

CompletedNCT05569343

Risk Factors for Achieving TO After LDPPHR-t

Risk Factors for Achieving Textbook Outcome After Laparoscopic Duodenum-preserving Total Pancreatic Head Resection: a Retrospective, Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
31 (actual)
Sponsor
Tongji Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

This is a single, retrospective, observational study to investigate the risk factors for achieving textbook outcome after laparoscopic duodenum-preserving total pancreatic head resection.

Detailed description

Increasing numbers of benign or low-grade malignant neoplasms at the head of pancreas are being diagnosed due to computed tomography (CT), magnetic resonance imaging (MRI) and endoscopic ultrasonography (EUS). Laparoscopic duodenum-preserving total pancreatic head resection (LDPPHR-t) has been accepted as a valid alternative treatment for benign and low-grade malignant neoplasms at the head of the pancreas. The evaluation of quality of LDPPHR-t is important for surgeons to improve surgical quality. Currently, the evaluation of surgical quality mainly depends on some single outcome indicators, such as morbidity, mortality, readmission rate, or hospital stay. These single outcome indicators are difficult to accurately reflect the overall surgical quality and the composite outcome measures may be better than single outcome indicators. Textbook outcome (TO) is such a composite concept and is realized when all the requirements after operation are achieved according to the "all or none" principle. TO reflects the ideal surgical outcome and is a multidimensional measure for surgical quality assurance. However, the risk factors for achieving TO after LDPPHR-t is unknown and no relevant articles have been reported so far. The objective of study was to identify the risk factors for achieving TO after LDPPHR-t.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionThis is an observational study without any intervention

Timeline

Start date
2020-05-08
Primary completion
2021-12-23
Completion
2022-04-16
First posted
2022-10-06
Last updated
2022-10-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05569343. Inclusion in this directory is not an endorsement.